This partnership aims to transform cell therapy workflows with Chain of Identity and Chain of Custody compliance standards.
ENCell’s investigational drug EN001 has been granted Orphan Drug Designation by the FDA for the treatment of ...
ProBioGen and Marea Therapeutics Inc. have successfully completed a sprint project to deliver clinical material for MAR002.
In an increasingly complex pharmaceutical landscape, companies face significant challenges in bringing their products from ...
Roche announced that the US Food and Drug Administration (FDA) has accepted the company’s supplemental Biologics License ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results